Comparison of FEV3 and FEV3/FVC Ratio Between Smokers and Non-Smokers Who Engage in Regular Exercise
Main Article Content
Introduction. Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD). In the early stages of disease, these pathological processes predominantly affects the small airways, known as Small Airway Disease (SAD), which is often clinically silent. FEV3 and FEV3/FVC ratio have been proposed as potential indicators of SAD. Regular exercise has been suggested to attenuate smoking-related pulmonary decline. However, evidence regarding its effect on small airway function in smokers in human studies, particularly among physically active individuals, remains limited. This study aimed to compare FEV3 and FEV3/FVC ratio between smokers and non-smokers who regularly engage in physical exercise. Methods. 30 adult male with regular exercise (18 smokers and 12 non-smokers) were included in this cross-sectional comparative study. Spirometric parameters, including percentage predicted values of Forced Expiratory Volume in three seconds (FEV3), and FEV3/FVC were measured and compared between groups using the independent samples t-test. Welch’s t-test was applied as a more robust method. Statistical analysis was computerized using Jamovi 2.3.28 software. Results. Non-smokers showed higher mean percentage predicted FEV3 and FVC compared with smokers. However, no significant differences in FEV3 (p= 0.608; effect sizes=-0.1870; 95% CI -0.911 to 0.555) and FEV3/FVC ratio (p= 0.100; effect sizes=0; 95% CI -0.487 to 0.984) between groups. Conclusion. This study found no significant differences in FEV3 or FEV3/FVC ratio between smokers and non-smokers with regular exercise. Further studies are needed to clarify the relationship between smoking, exercise, and early small airway impairment.
2. Madani A, Alack K, Richter MJ, Krüger K. Immune-regulating effects of exercise on cigarette smoke-induced inflammation. J Inflamm Res. 2018;11:155–167.
3. Kotlyarov S. The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis. Int J Mol Sci. 2023;24(10):8725.
4. Shandu NM, Mathunjwa ML, Shaw I, Shaw BS. Exercise Effects on Health-Related Quality of Life (HRQOL), Muscular Function, Cardiorespiratory Function, and Body Composition in Smokers: A Narrative Review. Int J Environ Res Public Health. 2023;20(19):6813.
5. Zhou R, Wang H, Zhang Y, Mai J, Yang L. Small airway disease as a key factor in COPD: new perspectives and insights. Front Med. 2025;12:1648612.
6. Zhou Z, Chen P, Peng H. Are healthy smokers really healthy?. Tob Induc Dis. 2016;14:35.
7. El Hussini MSH, El Husini MS. Forced expiratory volume in the third second and its derivatives for diagnosis of airway obstruction in obese patients. J Med Sci Res. 2022;5(2):147–154.
8. Gershon AS, Hwee J, Chapman KR, Aaron SD, O’Donnell DE, Stanbrook MB, et al. Factors associated with undiagnosed and overdiagnosed COPD. Eur Respir J. 2016. 48(2):561–564.
9. Morris ZQ, Coz A, Starosta D. An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest. 2013;144(4):1117–1123.
10. Li Y, Li J, Huang S, Wu F, Deng Z, Peng J, et al. Reduced FEV(3)/FVC as an Early Indicator of COPD in Individuals with Normal Spirometry: A Prospective Analysis from the ECOPD Study. Int J Chron Obstruct Pulmon Dis. 2025;20:3791–3802.
11. Pelkonen M, Notkola IL, Lakka T, Tukiainen HO, Kivinen P, Nissinen A. Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med. 2003;168(4):494–499.
12. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular Physical Activity Modifies Smoking-related Lung Function Decline and Reduces Risk of Chronic Obstructive Pulmonary Disease: A Population-based Cohort Study. Am J Respir Crit Care Med. 2007;175(5):458–463.
13. Antonelli A, Torchio R, Bertolaccini L, Terzi A, Rolfo F, Agostoni P, et al. Contribution of β-adrenergic receptors to exercise-induced bronchodilatation in healthy humans. Respir Physiol Neurobiol. 2012;184(1):55–59.
14. Chen X, Ma J, Dong L, Chen Y, Chen K. The association between physical activity and lung function in adolescents: a cross-sectional NHANES study. Front Med. 2025;12:1538221.
15. Toledo AC, Magalhaes RM, Hizume DC, Vieira RP, Biselli PJC, Moriya HT, et al. Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke. Eur Respir J. 2011;39(2):254–264.
16. Ishii M, Yamaguchi Y, Hamaya H, Ogawa S, Imura M, Akishita M. Characteristics of factors for decreased lung function in elderly patients with type 2 diabetes. Sci Rep. 2019;9(1):20206.
17. Lee YH, Shin MH, Kweon SS, Choi JS, Rhee JA, Ahn HR, et al. Cumulative smoking exposure, duration of smoking cessation, and peripheral arterial disease in middle-aged and older Korean men. BMC Public Health. 2011;11(1):94.
18. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153–161.
19. The jamovi project. jamovi. 2024.
20. Singh GY, Singh NL, Banik U, Devi GK. Detection of early small airway obstruction in male adult smokers of an ethnic community in north east India. J Med Soc. 2014;28(1).
21. Pisi R, Aiello M, Frizzelli A, Pisi G, Chetta A. Detection of Small Airway Dysfunction in Asymptomatic Smokers with Preserved Spirometry : The Value of the Impulse Oscillometry System. Int J Chron Obstruct Pulmon Dis. 2021;16:2585–2590.
22. Dugral E, Balkanci D. Effects of smoking and physical exercise on respiratory function test results in students of university: A cross-sectional study. Medicine (Baltimore). 2019;98(32):e16596.
